APA (7th ed.) Citation

Pepe, G., Capocci, L., Marracino, F., Realini, N., Lenzi, P., Martinello, K., . . . Maglione, V. (2023). Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease. Molecular therapy, 31(1), . https://doi.org/10.1016/j.ymthe.2022.09.004

Chicago Style (17th ed.) Citation

Pepe, Giuseppe, et al. "Treatment with THI, an Inhibitor of Sphingosine-1-phosphate Lyase, Modulates Glycosphingolipid Metabolism and Results Therapeutically Effective in Experimental Models of Huntington’s Disease." Molecular Therapy 31, no. 1 (2023). https://doi.org/10.1016/j.ymthe.2022.09.004.

MLA (9th ed.) Citation

Pepe, Giuseppe, et al. "Treatment with THI, an Inhibitor of Sphingosine-1-phosphate Lyase, Modulates Glycosphingolipid Metabolism and Results Therapeutically Effective in Experimental Models of Huntington’s Disease." Molecular Therapy, vol. 31, no. 1, 2023, https://doi.org/10.1016/j.ymthe.2022.09.004.